JUDITH ROMAN: Open Payments
NPI 1386109635 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 8 payments from 6 companies in 2025. Trend: 2023 $14 · 2024 $600 · 2025 $344
Food & beverage: $326Education: $18
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $126 |
| Vifor Pharma, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $35 |
| Travere Therapeutics, Inc. | 2 | $24 |
| OPKO Pharmaceuticals, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Veltassa, LOKELMA, IBSRELA, FARXIGA, RAYALDEE, JYNARQUE.
Industry payments across TX — which companies pay providers there.
